affective disorders

Related by string. Affective Disorders * Affective : non affective psychosis . affective psychosis . seasonal affective disorder . Seasonal Affective Disorder / disordered . Disorders . DISORDERS : sleep disordered breathing . autism spectrum disorders . eating disorders * Related Affective Disorders . Bipolar Affective Disorders . seasonal affective disorders *

Related by context. All words. (Click for frequent words.) 73 affective psychosis 73 euthymic patients 71 affective psychoses 71 nonpsychotic 71 comorbid depression 70 euthymic 70 somatic symptoms 70 somatoform disorders 69 psychiatric comorbidities 69 depressive symptomatology 69 alexithymia 69 comorbid anxiety 69 suicide attempters 69 dysthymic disorder 69 mood disorders 68 Comorbid 68 psychiatric morbidity 68 schizophrenia schizoaffective disorder 68 premorbid 68 hypochondriasis 67 Mood disorders 67 comorbid 67 affective disorder 67 comorbid disorders 67 mania hypomania 67 syndromal 67 depressive disorders 66 somatization 66 bipolar disorders 66 bulimia nervosa 66 autonomic dysfunction 66 subsyndromal 66 psychiatric disorders 66 Comorbidity 66 Cognitive behavioral 66 sociodemographic characteristics 66 somatization disorder 65 psychosocial functioning 65 unipolar depression 65 nondepressed 65 psychiatric comorbidity 65 #q#.# deletion syndrome 65 internalizing disorders 65 Neuroticism 65 subscale scores 65 externalizing disorders 65 depression irritability 65 neurological abnormalities 65 tic disorders 65 neurocognitive functioning 64 non affective psychosis 64 schizotypal 64 cognitive affective 64 Heritability 64 Suicidal ideation 64 schizophreniform disorder 64 Depressive symptoms 64 extrapyramidal symptoms 64 Cognitive impairment 64 dysthymia 64 bipolar affective disorder 64 impaired cognition 64 neuropsychological deficits 64 anxiety disorders 64 MMSE scores 64 Anxiety disorders 64 symptomatology 64 Sociodemographic 64 meta regression 64 puerperal psychosis 64 comorbidity 63 Generalized Anxiety Disorder 63 familial clustering 63 neuropsychiatric symptoms 63 multivariate analyzes 63 neurocognitive impairment 63 depressive symptom 63 nondemented 63 chronicity 63 familial aggregation 63 psychobiological 63 hyperarousal 63 behavioral disinhibition 63 depressive symptoms 63 nonpsychiatric 63 meta analytic review 63 comorbid psychiatric disorders 63 univariate analyzes 63 GH deficiency 63 syndromic 63 bivariate analyzes 63 comorbid psychiatric 63 neurocognitive function 63 probands 63 hippocampal volumes 63 #q# deletion syndrome 63 salivary cortisol 63 Interpersonal psychotherapy 63 psychotic disorders 63 interpersonal psychotherapy 63 somatic complaints 63 depression suicidal ideation 63 Exclusion criteria 63 premenstrual dysphoric disorder 63 HRQOL 63 emotional lability 62 shorter telomere length 62 sociodemographic variables 62 impaired glucose metabolism 62 APOE genotype 62 psychiatric diagnoses 62 bipolar illness 62 manic depression bipolar disorder 62 Atypical antipsychotics 62 poststroke 62 sub syndromal 62 neuropsychiatric disorder 62 subclinical atherosclerosis 62 TEAEs 62 diabetes mellitus hypertension 62 OSAHS 62 androgen deficiency 62 overactive bladder symptoms 62 psychiatric outpatients 62 clinicopathological 62 pharmacologic treatments 62 Posttraumatic stress disorder 62 covariate 62 dissociative disorders 62 gallstone disease 62 IPAH 62 Neuropsychological 62 psychiatric inpatients 62 Social Phobia 62 disorder OCD 62 fluoxetine paroxetine 62 psychosocial variables 62 diabetes mellitus DM 62 dopamine receptor gene 61 symptom severity 61 untreated psychosis 61 neuroimaging studies 61 abnormal lipid 61 abdominal adiposity 61 depression schizophrenia bipolar 61 parasomnias 61 subclinical hypothyroidism 61 thyrotropin levels 61 haematologic 61 fluoxetine Prozac 61 hypersomnia 61 nonadherence 61 neuropsychological impairments 61 Wernicke Korsakoff syndrome 61 STEP BD 61 thrombophilia 61 neurocognition 61 SRBD 61 neuroleptic 61 comorbid ADHD 61 Univariate analysis 61 depressive disorder 61 dysthymic 61 BMI z 61 subscales 61 generalized epilepsy 61 primary aldosteronism 61 Pharmacologic 61 polyarticular 61 neuroanatomical 61 attention-deficit/hyperactivity disorder ADHD 61 serotonin reuptake inhibitors 61 parkinsonism 61 multiple logistic regression 61 Psychopathy 61 functional gastrointestinal disorders 61 biopsychosocial 61 DSM IV diagnosis 61 Borderline personality 61 HAM D# 61 hypovitaminosis D 61 Oppositional Defiant Disorder 61 obstructive sleep 61 antenatal depression 61 comorbid conditions 61 Schizoaffective Disorder 61 % CI #.#-#.# [008] 61 hypomanic episodes 60 EEG abnormalities 60 avoidant personality disorder 60 CP CPPS 60 thyroid dysfunction 60 autoimmune thyroiditis 60 mood swings irritability 60 rheumatic disorders 60 irritability insomnia 60 Comorbidities 60 neuropsychological functioning 60 bipolar disorder schizophrenia 60 eating disorders anorexia nervosa 60 tryptophan depletion 60 atherogenic dyslipidemia 60 comorbid diagnoses 60 prefrontal cortical 60 Major depressive disorder 60 metabolic dysfunction 60 Antisocial Personality Disorder 60 aetiology 60 dysglycemia 60 recurrent abdominal pain 60 psychopathological symptoms 60 T1DM 60 Obsessive compulsive disorder OCD 60 dopamine antagonists 60 comorbid substance 60 Suicidal thoughts 60 odds ratios ORs 60 venlafaxine Effexor 60 neurosensory 60 autoimmune thyroid 60 sociodemographic 60 GBA mutations 60 cardiac malformations 60 prenatal exposures 60 testicular germ cell 60 parkinsonian 60 convulsive disorders 60 psychophysiological 60 headache abdominal pain 60 MMSE score 60 HRQoL 60 underdiagnosis 60 amisulpride 60 amnestic MCI 60 diathesis 60 sociodemographic factors 60 neurocognitive deficits 60 hypothalamic pituitary adrenal axis 60 T2DM 60 neuropathologic 60 Sjögren syndrome 60 neurologic disorders 60 somatoform disorder 60 cognitive domains 60 Major Depressive Disorder 60 manic depressive illness 60 neurobehavioural 60 5 HTTLPR 60 QoL 60 neurodevelopmental outcome 60 dementia praecox 59 reflux symptoms 59 suicidal ideation 59 serous ovarian cancer 59 neuropsychiatric diseases 59 borderline personality disorder 59 vasomotor 59 pharmacological interventions 59 body dysmorphic disorder 59 manic hypomanic 59 Prefrontal 59 highest tertile 59 antiphospholipid antibodies 59 narcolepsy cataplexy 59 HIV lipodystrophy 59 plasma folate 59 prostatic hyperplasia 59 cerebral infarctions 59 inattention hyperactivity 59 serum estradiol 59 Excessive daytime sleepiness 59 schizophrenia bipolar 59 Electrophysiological 59 HADS 59 predisposing factor 59 autistic traits 59 proband 59 hyperactivity inattention 59 elevated ALT 59 Mental disorders 59 Psychiatric Disorders 59 hematopoietic cancers 59 Nicotine dependence 59 neuroleptic drugs 59 multivariable adjusted 59 MGUS 59 prostate cancer CaP 59 atrophic gastritis 59 albumin excretion rate 59 allele frequencies 59 CVD mortality 59 Prostatitis 59 premenstrual syndrome PMS 59 hippocampal volume 59 HPA axis 59 cortisol secretion 59 BPRS 59 urolithiasis 59 bivariate 59 schizotypal traits 59 MetS 59 thyrotoxicosis 59 venlafaxine XR 59 nondiabetic patients 59 haematological 59 white matter hyperintensities 59 myeloproliferative neoplasms 59 LUTS 59 major depressive disorder 59 colorectal adenoma 59 suicide ideation 59 Pathological gambling 59 cognitive behavioral 59 HNPCC 59 logistic regression analyzes 59 habitual snoring 59 hepatic cirrhosis 59 schizophrenia 59 schizophreniform 59 androgen excess 59 prodromal 59 postpartum mood 59 carotid IMT 59 Montgomery Åsberg Depression 59 CC genotype 59 anxiety irritability 59 neuropsychiatric disorders 59 hereditary predisposition 59 convergent validity 59 cardiometabolic risk 59 psychoeducation 59 hematological parameters 59 noncardiac 59 elevated fasting glucose 59 prevalences 59 posttransplant 59 mental disorders 59 prospective longitudinal 59 clozapine Clozaril 59 plasma homocysteine 58 abstinent alcoholics 58 Bulimia Nervosa 58 frequent awakenings 58 monoclonal gammopathy 58 Personality disorders 58 subsyndromal depression 58 rCBF 58 neuroleptics 58 Korsakoff syndrome 58 akathisia 58 Brief Psychiatric 58 divalproex 58 hyperreflexia 58 hyperhomocysteinemia 58 echocardiographic parameters 58 amnestic 58 DQB1 * 58 neuropsychological assessment 58 hypertension diabetes mellitus 58 medically unexplained 58 intracerebral haemorrhage 58 hyperkinetic disorder 58 Chronic ITP 58 callous unemotional traits 58 Meta analyzes 58 thyrotropin 58 DRD2 58 depressive episodes 58 subthreshold depression 58 hypoglycaemic episodes 58 nonpregnant women 58 meta analytic 58 serum homocysteine 58 substance induced psychosis 58 tic severity 58 extramedullary 58 dissociative symptoms 58 antiphospholipid syndrome 58 serum folate concentrations 58 diabetes dyslipidemia 58 etiologic 58 heterozygous familial 58 prolonged QT interval 58 Psychodynamic 58 posttreatment 58 sensory gating 58 randomized controlled trials RCTs 58 VADT 58 Subgroup analyzes 58 pathophysiological mechanisms 58 lipid parameters 58 SGAs 58 posterior cingulate 58 daytime drowsiness 58 DSM IV Axis 58 anorexia nervosa bulimia nervosa 58 subthreshold 58 autosomal dominant inheritance 58 HRQL 58 aortic atherosclerosis 58 paroxetine Paxil 58 hyperlipidaemia 58 postoperative AF 58 bi polar disorders 58 Child Behavior Checklist 58 paroxetine sertraline 58 citalopram Celexa 58 cerebral infarction 58 nocturnal enuresis 58 risperidone Risperdal 58 depression anxiety 58 endophenotypes 58 electroencephalographic 58 monozygotic twin 58 subclinical disease 58 asthma rhinitis 58 clomipramine 58 subclinical hyperthyroidism 58 airway hyperresponsiveness 58 atherothrombotic disease 58 Y BOCS 58 HeFH 58 Cognitive dysfunction 58 silent myocardial ischemia 58 menstrual irregularity 58 serum lipid levels 58 colorectal adenomas 58 pediatric bipolar disorder 58 Psychosomatic Research 58 SGPT 58 interindividual variability 58 agomelatine 58 psychometric properties 58 daytime somnolence 58 logistic regression model 58 posttraumatic stress disorder 58 intracranial hypertension 58 recurrent venous thromboembolism 58 et al #a 58 Depressive Symptoms 58 Cognitive behavioral therapy 58 nulliparous women 58 dyslipidaemia 58 Hippocampal 58 overt hypothyroidism 58 clinically meaningful reductions 58 neurocognitive dysfunction 58 chronic renal insufficiency 58 ABCB1 58 carotid atherosclerosis 58 Bacterial vaginosis 58 df = 58 Ischemic 58 psychostimulants 58 dysphoric 58 Hyperactivity 58 polycystic ovary syndrome PCOS 58 Antisocial personality 58 microsatellite instability 58 sleep disturbances 58 gastrointestinal disturbances 58 cerebral microbleeds 58 nonalcoholic steatohepatitis NASH 58 perimenopausal women 58 Multivariate analyzes 58 psychopathology 58 histologic subtype 58 schizophrenics 58 extrapyramidal 58 dietary intakes 58 interpersonal psychotherapy IPT 58 mu opioid 58 Observational studies 58 psychiatric disorder 58 demyelinating 58 atherothrombotic 58 serotonergic 58 juvenile idiopathic arthritis JIA 58 multivariate adjustment 58 parietal cortices 58 idiopathic Parkinson disease 58 paraneoplastic 58 hyper IgE syndrome 58 cervicitis 58 hypomanic symptoms 58 diabetic polyneuropathy 58 Autistic Disorder 58 anorexia nervosa bulimia 58 fructose intolerance 58 androgen depletion 58 psychodynamic therapy 58 comorbidities 58 leiomyomas 58 prodromal phase 58 metabolic parameters 58 coronary calcification 58 lipid abnormalities 58 anticonvulsants 58 pharmacological therapies 58 quetiapine Seroquel 58 antidepressant efficacy 58 susceptibility loci 57 TT genotype 57 metaanalysis 57 obsessive compulsive disorders 57 clinicopathologic 57 Diagnostic Criteria 57 antiepileptics 57 plasma lipid 57 folate deficiency 57 coinfected patients 57 NNT = 57 Posttraumatic stress disorder PTSD 57 psychodynamic psychotherapy 57 hypercalciuria 57 histological subtype 57 psychopathological 57 macrovascular disease 57 unmeasured confounders 57 Selective serotonin reuptake inhibitors 57 left ventricular diastolic 57 Genetic predisposition 57 Klinefelter syndrome 57 lignan intake 57 Kraepelin 57 unprovoked seizures 57 Secondary efficacy endpoints 57 serum retinol 57 neuropsychological 57 allergic eczema 57 depression dysthymia 57 Main Outcome Measures 57 nortriptyline Pamelor 57 mucosal inflammation 57 hereditary hemochromatosis 57 Clinical manifestations 57 nonobese 57 univariate 57 YMRS 57 somnolence sedation 57 Electroconvulsive therapy 57 VaD 57 sexual dysfunctions 57 gastroesophageal reflux GERD 57 metabolic abnormalities 57 hypoactive 57 borderline personality disorders 57 serum urate levels 57 generalized estimating 57 orofacial pain 57 neuritic 57 generalized anxiety disorder GAD 57 neurologic abnormalities 57 probiotic supplementation 57 menstrual irregularities 57 hypoglycemic episodes 57 induce orthostatic hypotension 57 diagnosing ADHD 57 perinatal outcomes 57 daytime alertness 57 Depressive 57 Atopic 57 CLBP 57 epididymitis 57 premenstrual dysphoric disorder PMDD 57 highly heritable 57 #q# deletion 57 Nonspecific 57 rs# [004] 57 Trichotillomania 57 carotid stenosis 57 Glucocorticoids 57 carotid plaques 57 anhedonia 57 neuropathological 57 proliferative diabetic retinopathy 57 vestibular dysfunction 57 Anxiety Depression 57 APOE ε4 57 psychosocial stressors 57 Sleep disturbances 57 Nonalcoholic Fatty Liver Disease 57 genetic polymorphisms 57 atopic disorders 57 hyperprolactinemia 57 Leydig cell 57 pain catastrophizing 57 neuropsychological impairment 57 psychotherapies 57 multisystemic 57 nondiabetic 57 neurologic symptoms 57 decreased libido 57 familial pancreatic cancer 57 pharmacological approaches 57 GABRA2 57 gestational diabetes mellitus 57 neuro developmental 57 tic disorder 57 Sydenham chorea 57 arterial thickening 57 antidepressants antipsychotics 57 p = .# [002] 57 abacavir Ziagen 57 serum BDNF 57 delusions hallucinations 57 etiological 57 dysmenorrhoea 57 lupus scleroderma 57 hypothalamic pituitary 57 lipid lowering agents 57 nonalcoholic steatohepatitis 57 Index CDAI 57 Fluvoxamine 57 Bipolar Mania 57 POAG 57 intracranial stenosis 57 confidence interval #.#-#.# 57 IgA deficiency 57 irregular menses 57 Akathisia 57 tonsillar hypertrophy 57 atherothrombosis 57 genotypic resistance 57 Poisson regression 57 Logistic regression analysis 57 behavioral disturbances 57 mild renal insufficiency 57 5 HTTLPR genotype 57 neurobehavioral 57 tricyclic antidepressants TCAs 57 Subclinical 57 chlamydial infection 57 cognitive dysfunctions 57 migraineurs 57 AUDs 57 genetic loci 57 catechol O methyltransferase 57 retrospective cohort 57 Dental caries 57 rhinoconjunctivitis 57 syncopal 57 adjunctive placebo 57 myoclonus 57 PON1 activity 57 biochemical abnormalities 57 hamartomas 57 HIV HCV coinfected 57 Univariate 57 depressive illnesses 57 hypercoagulable 57 intima media thickness 57 schizoaffective disorders 57 neurodevelopmental impairment 57 artery stenosis 57 dysfunctional voiding 57 EoE 57 posttraumatic stress disorder PTSD 57 premenstrual symptoms 57 Posttraumatic 57 lipid lowering medication 57 lipid elevations 57 angiographically 57 psychiatric illnesses 57 antihypertensive therapy 57 generalized anxiety disorder 57 obesity insulin resistance 57 cerebrovascular disorders 57 UGT#A# * 57 onset diabetes mellitus 57 Exacerbations 57 Generalized anxiety disorder 57 sertraline Zoloft 57 BPS IC 57 Panic Disorder 57 albumin excretion 57 histopathological 57 episodic migraine 57 adenotonsillectomy 57 liver histology 57 hypophosphatemia 57 psychomotor retardation 57 nociceptive pain 57 atypical neuroleptics 57 SSc 57 bladder carcinoma 57 CYP#D# inhibitor 57 Attention-Deficit/Hyperactivity Disorder 57 Carbamazepine 57 depression suicidality 57 atopic 57 Prehypertension 57 Main Outcome Measure 57 hyperglycaemia 57 anxiety insomnia 56 Binge Eating Disorder 56 adiponectin concentrations 56 WCST 56 underwent coronary angiography 56 hypogonadotropic hypogonadism 56 sedatives hypnotics 56 ictal 56 diastolic hypertension 56 leukocyte counts 56 gastro esophageal reflux 56 cerebrovascular accidents 56 fasting plasma 56 logistic regression analysis 56 microvascular dysfunction 56 hypoperfusion 56 plasma homocysteine levels 56 opioid dependent 56 esotropia 56 tertiles 56 Socio demographic 56 electrophysiologic 56 monoamine oxidase inhibitors 56 hepatic enzyme 56 preoperative diagnosis 56 chronic prostatitis 56 Genetic susceptibility 56 Multivariate analysis 56 Mellaril 56 prepubertal 56 azoospermia 56 serum leptin 56 irritability mood swings 56 polyuria 56 serotonin norepinephrine 56 euthyroid 56 Mild Cognitive Impairment 56 postinjury 56 multivariable analysis 56 sCJD 56 nonfatal MI 56 chronic obstructive airway 56 elevated LDH 56 Adenomas 56 aMCI precursor 56 neurodevelopmental outcomes 56 etiologic factors 56 nosology 56 somnolence sleepiness 56 susceptibility locus 56 systolic hypertension 56 neurologic dysfunction 56 Atomoxetine 56 genetic polymorphism 56 Longitudinal studies 56 antioxidant supplementation 56 constipation nausea 56 β thalassemia 56 dyspareunia 56 Anorexia nervosa 56 normotensive 56 CHD mortality 56 5 HT1A 56 nighttime awakenings 56 lamotrigine 56 esophageal reflux 56 citalopram 56 HER2 overexpression 56 telomere lengths 56 DSM IV criteria 56 subscores 56 CORE OM 56 aminotransferases 56 depression suicidal thoughts 56 biobehavioral 56 Arrhythmias 56 internalizing behaviors 56 tumor subtype 56 Apolipoprotein E 56 inflammatory bowel syndrome 56 cognitive deficits 56 nasal polyposis 56 Impulsivity 56 Obsessive compulsive disorder 56 se xual 56 Sleep disordered breathing 56 anticholinergic drugs 56 covariates 56 interobserver 56 psychomotor agitation 56 antiandrogens 56 colorectal carcinogenesis 56 inhaled budesonide 56 primary dysmenorrhoea 56 dysbindin 56 Anticonvulsants 56 Heavy menstrual bleeding 56 pathophysiological processes 56 Neuropsychiatric 56 Socioeconomic status 56 KCNH2 56 virological response 56 Female Sexual Arousal 56 neurodevelopmental disorder 56 polycystic ovarian syndrome PCOS 56 Disorder ADHD 56 Binge eating 56 Alzheimer disease cognitive impairment 56 schizophrenia bipolar disorder 56 undiagnosed untreated 56 Structured Clinical 56 Zollinger Ellison syndrome 56 recurrent acute pancreatitis 56 Framingham Offspring 56 Functional neuroimaging 56 G6PD deficiency 56 idiopathic PAH 56 tricyclic antidepressants 56 Cytogenetic 56 Depression Inventory 56 aldosterone antagonist 56 extracellular dopamine 56 erection hardness 56 cholinergic tone 56 fibroids endometriosis 56 radiographic findings 56 multivariate logistic regression 56 spirometric 56 prospectively enrolled 56 nonfasting triglyceride levels 56 acute mania 56 developmental trajectories 56 SIADH 56 pathophysiologic 56 hereditary nonpolyposis colorectal cancer 56 elevated depressive symptoms 56 tipranavir ritonavir 56 hypercholesterolaemia 56 guideline concordant 56 vascular cognitive impairment 56 disorder FSAD 56 fatigue insomnia 56 psychostimulant 56 immunodeficiencies 56 Research www. elsevier.com 56 plasma lipids 56 Abilify aripiprazole 56 infarcts 56 pharmacological therapy 56 inversely associated 56 hormonal abnormalities 56 fasting insulin 56 COMT genotype 56 depressive moods 56 multivariable analyzes 56 neuronal dysfunction 56 DSM IV TR 56 cranial irradiation 56 aneurysmal subarachnoid hemorrhage 56 Irritable Bowel 56 psychomotor 56 Genetic variants 56 decompensated cirrhosis 56 PsA 56 lowest tertile 56 prolactin elevation 56 Attention-Deficit/Hyperactivity Disorder ADHD 56 nephrolithiasis 56 Endothelial function 56 urinary symptoms 56 aetiological 56 unrefreshing sleep 56 Hypertensive 56 Subtypes 56 Symptom Checklist 56 Bardet Biedl Syndrome 56 Depressive disorders 56 inotropic 56 recurrent DVT 56 dyslexia dyspraxia 56 symptomatic hyponatremia 56 amygdala reactivity 56 loop diuretics 56 causal pathways 56 HNSCC 56 monozygotic 56 hypoglycemic events 56 dopaminergic 56 Hypothalamic 56 Bruxism 56 vulvovaginal atrophy 56 impaired fasting glucose 56 prognostic factors 56 cirrhotic 56 chromium picolinate supplementation 56 thiopurine 56 psychotic symptoms 56 Conduct Disorder 56 Inhibitory 56 mild cognitive impairments 56 lacunar 56 Multiple logistic regression 56 monozygotic twins 56 RISPERDAL ® 56 causal pathway 56 post transplant lymphoproliferative 56 pulmonary dysfunction 56 Mental Disorders DSM IV 56 beta carotene supplementation 56 nondiabetic subjects 56 stratifying patients 56 ANCOVA 56 antidepressants SSRIs 56 triacylglycerol concentrations 56 juvenile idiopathic arthritis 56 tolterodine ER 56 induced akathisia 56 neuro developmental disorders 56 monoamine 56 hyperactivity impulsivity 56 nabilone 56 diabetic microvascular complications 56 SLC#A# [002] 56 Venous thromboembolism 56 semistructured interview 56 genetic locus 56 neuropsychological evaluations 56 macrovascular events 56 serum cortisol 56 pain syndromes 56 Schizophrenics 56 Acute Stress Disorder 56 airway reactivity 56 polysubstance abuse 56 Haptoglobin 56 dopamine D2 56 MTHFD1L gene 56 torsade de pointes 56 etiologies 56 imipramine Tofranil 56 Personality traits 56 essential thrombocythemia 56 PANSS scores 56 emotional dysregulation 56 premenopause 56 dopamine transporter gene 56 PON1 gene 56 WOMAC pain 56 Neurocognitive 56 microdeletion 56 laboratory abnormalities 56 confusional arousals 56 decompensated liver disease 56 idiopathic intracranial hypertension 56 comorbid illnesses 56 cardio metabolic 56 cryptogenic 56 perioperative complications 56 tranylcypromine 56 nonpharmacologic 56 bacterial prostatitis 56 Predictors 56 inotropic agents 56 compulsive hoarding syndrome 56 Dissociation 56 antiretroviral naïve 56 circadian genes 56 varicocele 56 antidepressants fluoxetine 56 parous women 56 EXJADE 56 PTPN# 56 QIDS SR 56 lysosomal storage disease 56 glycaemia 56 abnormal cytology 56 Alzheimer disease vascular dementia 56 memantine Namenda 56 primary biliary cirrhosis 56 LVNC 56 coinfection 56 lupus anticoagulant 56 cerebral glucose metabolism 56 endocannabinoid signaling 56 Parkinson Disease PD 56 univariate analysis 56 psychosocial 56 elevated serum creatinine 56 longitudinal cohort study 56 salmeterol HFA MDI 56 proliferative retinopathy 55 coronary stenosis 55 HBeAg negative patients 55 DSM IV 55 RLAI 55 chromosomal anomalies 55 confidence intervals CIs 55 biochemical imbalances 55 Symptom severity 55 hyperinsulinism 55 Electroencephalography 55 tegaserod 55 untreated celiac disease 55 IDDM 55 muscle dysmorphia

Back to home page